Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04990180
Other study ID # EDGE: 137907
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 14, 2021
Est. completion date February 28, 2023

Study information

Verified date May 2023
Source University Hospitals, Leicester
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The PReSent study seeks to clarify the need, develop and test the feasibility and acceptability of a shared decision making intervention to support patients with Chronic Obstructive Pulmonary Disease make decisions about Pulmonary Rehabilitation. The study is split into two parts; (1) an observational study of healthcare professionals implicit attitudes, and (2) a feasibility and acceptability study assessing the value of the newly developed shared decision making intervention including a patient decision aid and decision coaching.


Description:

Whilst Pulmonary Rehabilitation (PR) is an evidence-based intervention for patients with Chronic Obstructive Pulmonary Disease (COPD), the service suffers poor referral and uptake. One identified barrier to accessing PR at the University Hospitals of Leicester is healthcare professionals beliefs about patient motivation (e.g. believing patients to be unmotivated reduces their desire to offer PR). This shows healthcare professionals have conscious (explicit) bias but little is known about whether they also have unconscious (implicit) bias. It is important to measure this as it can also shape individuals attitudes and therefore referral behaviour. The first objective of this study is to measure healthcare professionals implicit bias. Healthcare professionals from the United Kingdom who refer patients to PR will be invited to complete a one-off computerised Implicit Association Test, adapted to measure their bias towards the behaviours of patients living with COPD (i.e. smoking, exercising). The second objective of this study is to test the feasibility and acceptability of a shared decision making intervention (a patient decision aid and decision coaching for PR specialists). Patients with COPD will receive the decision aid upon referral to PR and encouraged to use it to support their PR decision making. At their PR assessment they will engage in a shared decision making consultation with their trained PR specialist to decide on their preferred PR programme. Following completion/drop out from PR, patients and trained PR specialists will be invited to take part in either a focus group (patients) or interview (PR specialist) to discuss the acceptability of the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 144
Est. completion date February 28, 2023
Est. primary completion date February 23, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Phase 1: Measuring Healthcare Professionals attitudes towards patients with COPD Inclusion Criteria: - Willing and able to provide informed consent for participation in the research - A United Kingdom healthcare professional - A healthcare professional who has the capability to refer patients with COPD to Pulmonary Rehabilitation services - Male or female, aged 18+ years - Able to communicate in written and spoken English Exclusion Criteria: - Unable to provide valid informed consent - Healthcare professionals practising outside of the United Kingdom - A healthcare professional who does not refer patients with COPD to Pulmonary Rehabilitation services - Aged <18 years - Unable to understand written English as the Implicit Association Test is currently only available in English Phase 2: A Pulmonary Rehabilitation shared decision making intervention Patients:- Inclusion Criteria: - Willing and able to give informed consent for participation in the research - Male or female, aged 40+years - A confirmed diagnosis of COPD, post bronchodilator Forced Expiratory Volume 1/Full Vital Capacity ratio <70% - Eligible for attendance at a University Hospitals of Leicester Pulmonary Rehabilitation assessment - Able to communicate in written and spoken English Exclusion Criteria: - Unable to provide valid informed consent - Aged <40years - Primary diagnosis is another chronic respiratory condition. - Ineligible for attendance at a University Hospitals of Leicester PR assessment (e.g. significant comorbidity which limits exercise training - Unable to understand written English as the research information and shared decision making intervention is currently only available in English Healthcare professionals:- Inclusion Criteria: - A participant who is willing and able to give informed consent for participation in the research - A healthcare professional directly involved in the provision of the shared decision making intervention (e.g. a Pulmonary Rehabilitation specialist) - Male or female, aged 18+ years Exclusion criteria:- - A participant who is unable to provide valid informed consent - A healthcare professional not directly involved in the provision of the shared decision making intervention - Aged <18 years

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Shared Decision Making Intervention
Decision coaching will be provided to the Pulmonary Rehabilitation Specialists to provide the skills needed to facilitate shared decision making between themselves and patients (and carers). The patient decision aid will be an informational booklet which describes the available Pulmonary Rehabilitation options at the University Hospitals of Leicester. It will detail the risks and benefits of each option and provide interactive sections to engage patients with the content, guide them through it, encourage them to attribute personal meaning and preference to each one so they can make an informed and values-based decision about PR.

Locations

Country Name City State
United Kingdom University Hospitals of Leicester NHS Trust Leicester Leicestershire

Sponsors (1)

Lead Sponsor Collaborator
University Hospitals, Leicester

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Response latency Presence of bias between stimuli Baseline only
Primary Feasibility of recruitment assessed by rate of recruitment to time and target Recruitment to time (proposed study end date) and target (proposed sample size) Through study completion, an average of 1 year
Primary Feasibility of data collection/outcome measures assessed by rate of participant attrition Data completeness 1 year (end of study)
Primary Intervention fidelity assessed by the Observer OPTION 5 Scale This questionnaire is completed by the researcher when listening back to the shared decision making consultation audio recordings. It measures adherence to the principles of shared decision making. It is a 5 item questionnaire with a 4 point Likert Scale with scores ranging from 0-20. The higher the score the greater the adherence to the principles of shared decision making. 1 year (end of study)
Secondary Decisional conflict measured using the Decisional Conflict Scale The Decisional Conflict Scale is a self-reported, 16 item questionnaire with a 5 point Likert Scale with scores ranging from 0-64. The lower the score indicates lower decisional conflict. Baseline & immediately post intervention
Secondary Patient activation as measured by the Patient Activation Measure The Patient Activation Measure is a self-reported, 13 item questionnaire with a 5 point Likert Scale. Raw scores are transformed to a scaled score between of 0-100 with 100 indicating the highest activation in self-management. Baseline & immediately post intervention
Secondary Rate of attendance assessed by the proportion of participants who complete the intervention Intervention completion is termed as the number of participants who attend the shared decision making consultation. Baseline & immediately post intervention
Secondary Patient attitudes/experiences of the study assessed through qualitative interviews with study participants Patient attitudes/experiences of receiving the intervention 1 year (end of study)
Secondary Health professionals attitudes/experiences assessed through qualitative interviews with study participants Health professional attitudes/experiences of delivering the intervention 1 year (end of study)
Secondary Uptake and adherence to Pulmonary Rehabilitation assessed by the proportion of participants who begin and complete Pulmonary Rehabilitation Completion is termed as participants who complete at least 8 of the available 12 sessions (75%). Baseline & immediately post intervention
Secondary COPD Assessment Test The COPD Assessment Test is a self-reported, 8 item questionnaire with a 6 point Likert Scale with scores ranging from 0-40. Higher scores indicate lower health-related quality of life. Baseline & immediately post intervention
Secondary Bristol COPD Knowledge Questionnaire The Bristol COPD Knowledge questionnaire is a multiple choice, 65 item self-reported questionnaire. Scores range from 0-65 with higher scores indicating greater knowledge of COPD. Baseline & immediately post intervention
Secondary Chronic Respiratory Questionnaire The Chronic Respiratory Questionnaire is a self-reported 20 item questionnaire using a 7 point Likert Scale. Scores range from 7-140 with higher scores indicating greater health-related quality of life. Baseline & immediately post intervention
Secondary Hospital Anxiety and Depression Scale The Hospital Anxiety and Depression Scale is a multiple choice, 14 item questionnaire using a 4 point Likert scale. Scores range from 0-42 with higher scores indicating greater levels of anxiety and/or depression. Baseline & immediately post intervention
Secondary COPD Prem 9 The COPD Prem 9 is a self-reported, 9 item questionnaire with a 6 point Likert scale. Scores range from 0-45 with lower scores indicating better health-related quality of life. Baseline & immediately post intervention
Secondary Medical Research Council Dyspnoea Scale The Medical Research Council Dyspnoea Scale is a self-reported, 1 item questionnaire using a 5 point Likert Scale. Scores range from 1-5 with higher scores indicating greater perceived breathlessness. Baseline & immediately post intervention
Secondary Incremental Shuttle Walking Test Maximal exercise capacity test Baseline & immediately post intervention
Secondary Endurance Shuttle Walking Test Maximal exercise capacity test Baseline & immediately post intervention
Secondary Patient satisfaction with Pulmonary Rehabilitation assessed by internal hospital satisfaction questionnaire This is a 6 item open ended questionnaire exploring patient satisfaction with Pulmonary Rehabilitation. The text is analysed using qualitative research methods. Baseline & immediately post intervention
See also
  Status Clinical Trial Phase
Completed NCT05043428 - The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD N/A
Completed NCT00528996 - An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. Phase 2
Completed NCT03740373 - A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate Phase 1
Completed NCT05402020 - Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
Completed NCT05393245 - Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
Completed NCT04011735 - Re-usable Respimat® Soft MistTM Inhaler Study
Enrolling by invitation NCT03075709 - The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
Completed NCT03764163 - Image and Model Based Analysis of Lung Disease Early Phase 1
Completed NCT00515268 - Endotoxin Challenge Study For Healthy Men and Women Phase 1
Completed NCT04085302 - TARA Working Prototype Engagement Evaluation: Feasibility Study N/A
Completed NCT03691324 - Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study N/A
Completed NCT02236611 - A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT00153075 - Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT01009463 - A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT01017952 - A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT04882124 - Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD Phase 2
Completed NCT02853123 - Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients Phase 4
Completed NCT02619357 - Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma Phase 1
Recruiting NCT05858463 - High Intensity Interval Training and Muscle Adaptations During PR N/A
Not yet recruiting NCT05032898 - Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II